 |
| Chairperson and MD, Biocon, Kiran Mazumdar-Shaw |
- Indian biotechnology firm announced launch of first drug for Psoriosis (a skin disease).
- The drug is called ALZUMAb, which took 10 years of R&D before it was released.
- It is supposed to affect 1-2% of Indian population.
